News

Precision Medicine Online55m
Atsena Gets FDA Nod for Expanded Trial, Paving Faster Path to Market for XLRS Gene Therapy
The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...